Search filters

List of works by Silvia Nozza

A case of HIV-associated fever of unknown origin: deficit of IL-1β antagonistic activity and resolution with monocyte–granulocyte apheresis

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses

scientific article published on 22 September 2011

Ageing with HIV: a multidisciplinary review.

scientific article published on 19 May 2015

Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study

scientific article

B-cell subset alterations and correlated factors in HIV-1 infection

scientific article published on May 2013

Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets

scientific article published on 16 October 2015

Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescent

scientific article

Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients

scientific article published in February 2011

Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: maraviroc, raltegravir, etravirine

scientific article published in April 2011

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting

scientific article

Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.

scientific article published on 13 May 2015

Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 infection

scientific article published on 8 June 2016

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy

scientific article published on 30 July 2015

Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.

scientific article published on 13 April 2001

Erratum to: Ageing with HIV: a multidisciplinary review.

scientific article

Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis

article

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir

scientific article published on May 2016

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients.

scientific article published on 23 May 2014

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption

scientific article

Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1.

scientific article

Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.

scientific article

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group

scientific article published on 22 October 2013

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients.

scientific article published on 13 October 2014

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients

scientific article published on 11 January 2018

Identification and experimental validation of an HIV model for HAART treated patients.

scientific article published on 19 August 2013

Immortal time bias: authors' reply

scientific article published in April 2015

Immune recovery and T cell subset analysis during effective treatment with maraviroc

scientific article published on 7 June 2012

Immunological recovery after 24 weeks of antiretroviral therapy in patients with X4 virus during primary HIV infection

scientific article published in January 2014

Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration

article

Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals

scientific article

Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors' reply

scientific article published in April 2015

Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2

article

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology

scientific article published on April 2014

Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients

scientific article (publication date: 2012)

Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens

scientific article published in September 2012

Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study

scientific article published on 11 December 2014

Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up

scientific article published on 31 October 2016

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism

scientific article published on December 2010

Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men

scientific article published on 03 July 2022

Monotherapy With Atazanavir as a Simplificati Strategy

Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretrovirals

scientific article published on May 2004

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

scientific article published on 5 February 2016

Oral CCR5 inhibitors: will they make it through?

scientific article

Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients

scientific article

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group

scientific article

Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2.

scientific article

Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients

scientific article published on 14 March 2013

Pharmacokinetics of the raltegravir/maraviroc/etravirine combination

scientific article published on 04 June 2011

Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort

scientific article published on 5 December 2017

Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient

scientific article published on 11 July 2013

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

scientific article published in March 2010

Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients

scientific article published on 8 May 2014

Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results

scientific article

Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART.

scientific article

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study.

scientific article

The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection

scientific article published on June 30, 2012

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.

scientific article

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

scientific article

Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.

scientific article published in May 2002

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy

scientific article

Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection

scientific article published on 23 January 2014

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

scientific article published on 31 January 2012

Paulina is supported by:

About Paulina

Help